Lsp2 Protein Links mTORC1 to TOP mRNA Translation and Lifespan

Researchers have identified the protein Lsp2 as a critical link between the mTORC1 signaling pathway and the translation of TOP (Terminal Oligopyrimidine) mRNAs, a process that directly impacts lifespan in the fruit fly Drosophila melanogaster. The findings, published online in Nature on September 23, 2026, detail how Lsp2, a protein that is upregulated in response to dietary essential amino acids, acts as a physiological effector of mTORC1. This discovery sheds new light on the complex molecular mechanisms governing aging and metabolic regulation.

The study demonstrates that mutant Drosophila lacking the Lsp2 gene exhibit a significant reduction in the translation of TOP mRNAs. TOP mRNAs are a class of messenger RNAs that encode proteins involved in fundamental cellular processes, including ribosome biogenesis and translation initiation. Their efficient translation is crucial for cell growth and function. The impaired translation of these vital mRNAs in Lsp2-deficient flies is associated with a notable improvement in longevity. This suggests that modulating Lsp2 activity could be a potential strategy for extending lifespan.

The mTORC1 (mechanistic Target of Rapamycin Complex 1) pathway is a central regulator of cell growth, metabolism, and protein synthesis, and it is known to play a significant role in aging. By identifying Lsp2 as a key effector of mTORC1, this research provides a more granular understanding of how this pathway influences cellular processes at the translational level. The induction of Lsp2 by essential amino acids further emphasizes the connection between nutrient availability and the regulation of protein synthesis and aging.

This work builds upon previous knowledge of mTORC1's role in aging and metabolic health, extending it to the specific mechanisms involving mRNA translation. The observation that flies lacking Lsp2 live longer highlights a potential trade-off between growth and longevity, where reduced protein synthesis, driven by the absence of Lsp2, may conserve resources and delay aging. Future research may explore whether similar mechanisms are conserved in other organisms, including mammals, and investigate the therapeutic potential of targeting Lsp2 or related pathways for age-related diseases.